Use of a Visual Analog Scale to Assess Pain of Injection with Intracavernous Injection Therapy
Authors:
- 1 May 2005
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 2 (3) , 428-431
Abstract
Aim Fear of pain with intracavernosal injection (ICI) therapy may discourage its use in patients with erectile dysfunction (ED). Methods We prospectively analyzed patient self‐report of discomfort with ICI therapy for ED utilizing a visual analog scale from 0 to 10. Results Patient self‐report using a visual analog scale revealed minimal discomfort, with 59 consecutive patients reporting an average pain score of 1.93 ± 1.76. There was no statistical difference between self‐administered or nurse‐administered injections. The volume of the injection also had no statistical effect on pain score, and there was no difference observed between those who received alprostadil alone or combination treatment. Patients with diabetes mellitus did have significantly higher pain scores than other patients (3.31 ± 2.25 vs. 1.62 ± 1.39, P = 0.009), even when controlling for other factors. Conclusion Clinicians should be aware of the greater potential for discomfort in ED patients with diabetes. In the majority of ED patients, however, discomfort is minimal, and this information should be helpful in alleviating fear of injection in those who may benefit from this therapy.Keywords
This publication has 4 references indexed in Scilit:
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Comparative Study of Papaverine Plus Phentolamine Versus Prostaglandin E1 in Erectile DysfunctionJournal of Urology, 1997
- The effects of stress and coping upon the diagnostic intracavernous injection in men with erectile dysfunctionJournal of Psychosomatic Research, 1995
- Pharmacological Erection Program Using Prostaglandin E1Journal of Urology, 1991